Comparative Efficacy of Meropenem Versus Meropenem Combined with Azithromycin in Treating Extensively Drug-Resistant Uncomplicated Typhoid Fever
DOI:
https://doi.org/10.37762/jgmds.13-3.905Keywords:
XDR, Salmonella Typhi, Pediatric Patients, Meropenem, AzithromycinAbstract
ABSTRACT
OBJECTIVES
To compare the effectiveness of treating children with meropenem monotherapy vs meropenem plus azithromycin for cases of unexplained typhoid fever that have developed resistance to other drugs.
METHODOLOGY
This study aimed to compare the clinical efficacy and safety of meropenem alone versus meropenem combined with azithromycin in treating pediatric patients with XDR uncomplicated typhoid fever in a randomised controlled trial (ClinicalTrials.gov Identifier: NCT07445282). Over 6 months, a randomised controlled trial was conducted at the Department of Pediatric Medicine at Sheikh Zayed Hospital in Rahim Yar Khan. Ninety children, aged six months to under five years, with blood-culture–confirmed XDR S. Typhi were included and randomly divided into two groups. Group A received meropenem IV (20–40 mg/kg every 8 hours), and Group B received meropenem and azithromycin by mouth (20 mg/kg/day). The main goal was the average time it took for the fever to go down. We used SPSS version 25.0 to analyse the data, setting the p-value to 0.05.
RESULTS
The mean time to defervescence was significantly shorter in the combination group (5.4 ± 2.1 days) than in the meropenem group (6.5 ± 2.8 days; p = 0.02). In the combination group, 93.3% of patients saw clinical improvement, while in the monotherapy group, only 82.2% did (p = 0.04). The dual regimen significantly reduced the mean time to ovulation and the frequency of clinical alterations, without a significant increase in adverse events, compared with the monotherapy or the combination therapy in young children with severe drug-resistant (XDR) straightforward fever.
CONCLUSION
This study provides substantial evidence for optimising antibiotic therapy in pediatric XDR tachycardia by systematically assessing the clinical outcomes of two therapeutic regimens. The results are anticipated to enhance clinical practice, inform antibiotic stewardship initiatives, and support the global effort to mitigate antimicrobial resistance.
Downloads
Metrics
References
Boakye Okyere P, Twumasi-Ankrah S, Newton S, Nkansah-Darko S, Owusu Ansah M, Darko E, et al. Risk factors for typhoid fever: a systematic review. JMIR Public Health Surveill. 2025;11:e67544. doi: https://doi.org/10.2196/67544. PMID: 40357939 DOI: https://doi.org/10.2196/67544
Gashaw T, Jambo A. Typhoid in less developed countries: a major public health concern. In: Chaurasiya AK, editor. Hygiene and Health in Developing Countries: Recent Advances. London: IntechOpen; 2022. doi: https://doi.org/10.5772/intechopen.102214 DOI: https://doi.org/10.5772/intechopen.108109
Kirti N, Krishna SS, Shukla D. Salmonella infections: an update, detection and control strategies. In: Salmonella—Current Trends and Perspectives in Detection and Control. London: IntechOpen; 2024. doi: https://doi.org/10.5772/intechopen.113031 DOI: https://doi.org/10.5772/intechopen.1004835
Altun SK, Aydemir ME, Alkan S. A global bibliometric analysis of Salmonella Typhi over the past 52 years (1970–2022). J Infect Dev Ctries. 2025;19(5):691-698. doi: https://doi.org/10.3855/jidc.20141. PMID: 40451748 DOI: https://doi.org/10.3855/jidc.17946
Khan M, Shamim S. Understanding the mechanism of antimicrobial resistance and pathogenesis of Salmonella enterica serovar Typhi. Microorganisms. 2022;10(10):2006. doi: https://doi.org/10.3390/microorganisms10102006. PMID: 36296618 DOI: https://doi.org/10.3390/microorganisms10102006
Eng S-K, Pusparajah P, Ab Mutalib N-S, Ser H-L, Chan K-G, Lee L-H. Salmonella: a review on pathogenesis, epidemiology and antibiotic resistance. Front Life Sci. 2015;8(3):284-293. doi: https://doi.org/10.1080/21553769.2015.1051243 DOI: https://doi.org/10.1080/21553769.2015.1051243
Crump JA, Sjölund-Karlsson M, Gordon MA, Parry CM. Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections. Clin Microbiol Rev. 2015;28(4):901-937. doi: https://doi.org/10.1128/CMR.00002-15. PMID: 26180063 DOI: https://doi.org/10.1128/CMR.00002-15
Zakir M, Khan M, Umar MI, Murtaza G, Ashraf M, Shamim S. Emerging trends of multidrug-resistant and extensively drug-resistant Salmonella Typhi in a tertiary care hospital of Lahore, Pakistan. Microorganisms. 2021;9(12):2484. doi: https://doi.org/10.3390/microorganisms9122484. PMID: 34946016 DOI: https://doi.org/10.3390/microorganisms9122484
Gajic I, Tomic N, Lukovic B, Jovicevic M, Kekic D, Petrovic M, et al. A comprehensive overview of antibacterial agents for combating multidrug-resistant bacteria: current landscape, development, future opportunities, and challenges. Antibiotics (Basel). 2025;14(3):221. doi: https://doi.org/10.3390/antibiotics14030221. PMID: 40139652
Tajammul A, Benson S, Ahmed J, VanDerslice J, Tanner WD. Detection of Salmonella Typhi and blaCTX-M genes in drinking water, wastewater, and environmental biofilms in Sindh Province, Pakistan. PLoS Negl Trop Dis. 2025;19(4):e0012963. doi: https://doi.org/10.1371/journal.pntd.0012963. PMID: 40216439 DOI: https://doi.org/10.1371/journal.pntd.0012963
Klemm EJ, Shakoor S, Page AJ, Qamar FN, Judge K, Saeed DK, Wong VK, Dallman TJ, Nair S, Baker S, Shaheen G, Qureshi S, Yousafzai MT, Saleem MK, Hasan Z, Dougan G, Hasan R. Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. mBio. 2018;9(1):e00105-18. doi: 10.1128/mBio.00105-18. PMID: 29463654 DOI: https://doi.org/10.1128/mBio.00105-18
Browne AJ, Kashef Hamadani BH, Kumaran EAP, Rao P, Longbottom J, Harriss E, et al. Drug-resistant enteric fever worldwide, 1990–2018: a systematic review and meta-analysis. BMC Med. 2020;18:1. doi: 10.1186/s12916-019-1443-1. PMID: 31888700 DOI: https://doi.org/10.1186/s12916-019-1443-1
Britto CD, Wong VK, Dougan G, Pollard AJ. A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid. PLoS Negl Trop Dis. 2018;12(10):e0006779. doi: 10.1371/journal.pntd.0006779. PMID: 30312388 DOI: https://doi.org/10.1371/journal.pntd.0006779
Yousafzai MT, Qamar FN, Shakoor S, Saleem K, Lohana H, Karim S, et al. Ceftriaxone-resistant Salmonella Typhi outbreak in Hyderabad City of Sindh, Pakistan: High time for the introduction of typhoid conjugate vaccine. Clin Infect Dis. 2019;68(Suppl 1):S16-S21. doi: 10.1093/cid/ciy877. PMID: 30767003 DOI: https://doi.org/10.1093/cid/ciy877
Akram J, Khan AS, Khan HA, Gilani SA, Akram SJ, Ahmad FJ, Mehboob R. Extensively drug-resistant (XDR) typhoid: evolution, prevention and its management. Biomed Res Int. 2020;2020:6432580. doi: 10.1155/2020/6432580. PMID: 32462008 DOI: https://doi.org/10.1155/2020/6432580
Qureshi S, Naveed AB, Yousafzai MT, Ahmad K, Ansari S, Lohana H, et al. Response of extensively drug-resistant Salmonella Typhi to treatment with meropenem and azithromycin in Pakistan. PLoS Negl Trop Dis. 2020;14(10):e0008682. doi: 10.1371/journal.pntd.0008682. PMID: 33052979
Butt MH, Saleem A, Javed SO, Ullah I, Rehman MU, Islam N, et al. Rising XDR-typhoid fever cases in Pakistan: Are we heading back to the pre-antibiotic era? Front Public Health. 2022;9:794868. doi: 10.3389/fpubh.2021.794868. PMID: 35071061
Shahid S, Mahesar M, Ghouri N, Noreen S. A review of clinical profile, complications and antibiotic susceptibility pattern of extensively drug-resistant (XDR) Salmonella Typhi isolates in children in Karachi. BMC Infect Dis. 2021;21(1):900. doi: 10.1186/s12879-021-06618-3. PMID: 34544427 DOI: https://doi.org/10.1186/s12879-021-06599-2
Carey ME, Dyson ZA, Ingle DJ, Amir A, Aworh MK, Chattaway MA, et al. Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes. eLife. 2023;12:e85867. doi: 10.7554/eLife.85867. PMID: 37603689 DOI: https://doi.org/10.7554/eLife.85867
Heidary M, Ebrahimi Samangani A, Kargari A, Kiani Nejad A, Yashmi I, Motahar M, et al. Mechanism of action, resistance, synergism, and clinical implications of azithromycin. J Clin Lab Anal. 2022;36(6):e24427. doi: 10.1002/jcla.24427. PMID: 35419871 DOI: https://doi.org/10.1002/jcla.24427
Khalid H, Rehman Z, Kabir M, Razaq N, Riaz K, Afnan Z, et al. Clinical characteristics and resistance patterns of extensively drug-resistant Salmonella Typhi in the pediatric population of Pakistan: a prospective study. SAGE Open Med. 2026;14:20503121261140860. doi: 10.1177/20503121261140860. PMID: Available after MEDLINE indexing DOI: https://doi.org/10.1177/30502225251408603
Shao Z, Zhu J, Wei Y, Jin J, Liu J, Sun R, et al. Clinical impact of droplet digital PCR-guided antibiotic stewardship on prognosis in patients with suspected bloodstream infection: a prospective observational study. Infect Dis Ther. 2026. doi: 10.1007/s40121-026-01155-0. PMID: Available after MEDLINE indexing DOI: https://doi.org/10.1007/s40121-026-01305-8
Butt MH, Saleem A, Javed SO, Ullah I, Rehman MU, Islam N, et al. Rising XDR-typhoid fever cases in Pakistan: are we heading back to the pre-antibiotic era? Front Public Health. 2022;9:794868. doi: 10.3389/fpubh.2021.794868. PMID: 35071061 DOI: https://doi.org/10.3389/fpubh.2021.794868
Riaz U, Qayyum Z, Sattar A, Riaz Z. Fighting XDR typhoid: a hospital-based study on clinical aspects and treatment outcome in a tertiary care hospital. Ann PIMS Shaheed Zulfiqar Ali Bhutto Med Univ. 2024;20(Suppl 1):546-549 DOI: https://doi.org/10.48036/apims.v20iSUPPL-1.1142
Qureshi S, Naveed AB, Yousafzai MT, Ahmad K, Ansari S, Lohana H, et al. Response of extensively drug-resistant Salmonella Typhi to treatment with meropenem and azithromycin in Pakistan. PLoS Negl Trop Dis. 2020;14(10):e0008682. doi: 10.1371/journal.pntd.0008682. PMID: 33052979 DOI: https://doi.org/10.1371/journal.pntd.0008682
Gajic I, Tomic N, Lukovic B, Jovicevic M, Kekic D, Petrovic M, et al. A comprehensive overview of antibacterial agents for combating multidrug-resistant bacteria: current landscape, development, future opportunities, and challenges. Antibiotics (Basel). 2025;14(3):221. doi: 10.3390/antibiotics14030221. PMID: 40128211 DOI: https://doi.org/10.3390/antibiotics14030221
Karnwal A, Jassim AY, Mohammed AA, Al-Tawaha ARMS, Selvaraj M, Malik T. Addressing the global challenge of bacterial drug resistance: insights, strategies, and future directions. Front Microbiol. 2025;16:1517772. doi: 10.3389/fmicb.2025.1517772. PMID: 40097867 DOI: https://doi.org/10.3389/fmicb.2025.1517772
Musumeci S, Kruse A, Chappuis F, Ostergaard Jensen T, Alcoba G. Neglected etiologies of prolonged febrile illness in tropical and subtropical regions: a systematic review. PLoS Negl Trop Dis. 2024;18(6):e0011978. doi: 10.1371/journal.pntd.0011978. PMID: 38808867 DOI: https://doi.org/10.1371/journal.pntd.0011978
Verrest L, Dorlo TPC. Lack of clinical pharmacokinetic studies to optimize the treatment of neglected tropical diseases: a systematic review. Clin Pharmacokinet. 2017;56(6):583-606. doi: 10.1007/s40262-016-0467-4. PMID: 27734259 DOI: https://doi.org/10.1007/s40262-016-0467-3
Shahid S, Mahesar M, Ghouri N, Noreen S. A review of clinical profile, complications and antibiotic susceptibility pattern of extensively drug-resistant Salmonella Typhi isolates in children in Karachi. BMC Infect Dis. 2021;21(1):900. doi: 10.1186/s12879-021-06618-3. PMID: 34544427 DOI: https://doi.org/10.21203/rs.3.rs-51063/v2
Sullivan KM, Dean A, Soe MM. OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Rep. 2009;124(3):471-474. doi: 10.1177/003335490912400320. PMID: 19445426. DOI: https://doi.org/10.1177/003335490912400320
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Fawad Ahmad, Jamal Anwer, Hafiz Muhammad Usman Ali Ashraf Ahmad, Sajida Khalid
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
